Proteins that specifically recognize cisplatin-damaged DNA: A clue to anticancer activity of cisplatin

FASEB Journal

Volumn 12, Issue 10, 1998, Pages 791-799

  Zlatanova, Jordanka ^a,b,d   Yaneva, Julia ^a,c   Leuba, Sanford H ^a,d  

^a OREGON STATE UNIVERSITY   (United States)

^b INSTITUTE OF PHYSIOLOGY   (Bulgaria)

^c INSTITUTE OF MOLECULAR BIOLOGY   (Bulgaria)

^d ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Anticancer drugs; DDP; DNA adducts; Transplatin

Indexed keywords

CISPLATIN; TRANSPLATIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING SITE; COVALENT BOND; CYTOTOXICITY; DNA ADDUCT; DNA CROSS LINKING; DNA REPAIR; DRUG ACTIVITY; DRUG PROTEIN BINDING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MODIFICATION; PROTEIN STRUCTURE;

EID: 0031801634     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.12.10.791     Document Type: Article

References (63)

1. Loehrer, P. J., and Einhorn, L. H. (1984) Cisplatin. Ann. Int. Med. 100, 704-713
2. Muggia, F. M. (1991) Cisplatin update. Semin. Oncol 18, 1-4
3. Einhorn, L. H. (1994) Salvage therapy for germ cell tumors. Semin. Oncol 21, 47-51
4. Muggia, F. M., and Muderspach, L. (1994) Platinum compounds in cervical and endometrial cancers: focus on carboplatin. Semin. Oncol. 21, 35-41
5. Rosenberg, B., van Camp, L., and Krigas, T. (1965) Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature (London) 205, 698-699
6. Sherman, S. E., and Lippard, S. J. (1987) Structural aspects of platinum anticancer drug interactions with DNA. Chem. Rev. 86, 1153-1181
7. Leng, M., and Brabec, V. (1994) DNA adducts of cisplatin, transplatin and platinum-intercalating drugs. In DNA Adducts: Identification and Biological Significance (Hemminki, K., et al., eds) pp. 339-348, IARC Scientific Publications No. 125, International Agency for Research on Cancer, Lyons, France
8. Takahara, P. M., Rosenzweig, A. C., Frederick, C. A., and Lippard, S.J. (1995) Crystal structure of double-stranded DNA containing the major adduct of the antirancer drug cisplatin. Nature (London) 377, 649-652
9. Yang, D., van Bloom, S. S. G. E., Reedijk, J., van Bloom, J. H., and Wang, A. H.-J. (1995) Structure and isomerization of an intrastrand cisplatin-cross-linked octamer DNA duplex by NMR analysis. Biochemistry 34, 12912-12920
10. Huang, H., Zhu, L., Reid, B. R., Drobny, G. P., and Hopkins, P. B. (1995) Solution structure of a cisplatin-induced DNA in an interstraud cross-link. Science 270, 1842-1845
11. Paquet, F., Férez, C., Leng, M., Lancelot, G., and Malinge, J.-M. (1996) NMR solution structure of a DNA decamer containing an interstrand cross-link of the antitumor drug riwliamminedichloroplatinum(II). J. Biomol. Str. Dyn. 14, 67-77
12. Lilley, D. M. J. (1996) Cisplatin adducts in DNA: distortion and recognition. JBIC 1, 189-191
13. Bellon, S. F., Coleman, J. H., and Lippard, S. J. (1991) DNA unwinding produced by site-specific intrastrand cross-links of the antitumor drug cis-diamininedichloroplatinum(II), Biochemistry 30, 8026-8035
14. Comess, K. M., and Lippard, S. J. (1993) Molecular aspects of platinum-DNA interactions. In Molecular Aspects of Anticancer Drug-DNA Intrractions (Neidle, S., and Waring, M., eds) Vol. 1, pp. 134-168, CRC Press, Boca Raton, Florida
15. Chu, G. (1994) Cellular responses to cisphuin.J. Biol. Chrm. 269, 787-790
16. Sorenson, C. M., and Eastman, A. (1988) Influence of cis-cliam-minedichloroplatinum(II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient Chinese hamster orary cells. Cancer Res, 48, 6703-6707
17. Mello, J. A., Lippard, S. J., and Essigmann, J. M. (1995) DNA adducts of cis-diamminedichloroplatinum(II) and its trans isomer inhibit RNA polymerase II differentially in vivo. Biochemistry 34, 14783-14791.
18. Mymryk, J. S., Zaniewski, E., and Archer, T. K. (1995) Cisplatin inhibits chromatin remodeling, transcription factor binding, and transcription from the mouse mammary tumor virus promoter in vivo. Proc, Natl. Acad. Sci. USA 92, 2076-2080
19. Ferez, R. P., Hamilton., T. C., Ozols, R. F., and Young, R.C. (1993) Mechanisms and. modulation of resistance to ehemo-therapy in ovarian cancer. Coner 71, 1571-1580
20. Toney, J. H., Donahue, B. A., Kellett, P. J., Bruhn, S. L., Essigmann, J. M., and Lippard, S. J. (1989) Isolation of cDNAs encoding a human protein that binds selectively to DNA modified by the anticancer drug cis-diamminedichloroplatinum(II). Proc. Natl. Acad. Sci. USA 86, 8328-8332
21. Donahue, B. A., Augot, M., Bellon, S. F., Treiber, D. K., Toney, J. H., Lippard, S.J., and Essigmann, J. M. (1990) Characterization of a DNA damage-recognition protein from mammalian cells chat binds specifically to intrastrand d(GpG) und d(ApG) DNA adducts of the anticancer drug cisplatin. Biochemistry 29, 5872-5880
22. Chu, G., and Chang, E. (1990) Cisplatin-resisfunt cells express increased levels of a factor that recognizes damaged DNA. Proc. Natl. Acad. Sci. USA 87, 3324-3327
23. Jones, C. J., and Wood, R. D. (1993) Preferential binding of the Xeroderma pigmentosum group A complementing protein to damaged DNA. Biochemistry 32, 12096-12104
24. Asahina, H., Kuraoka, I., Shirakawa, M., Morita, E. H., Miura, N., Miymoto, I., Ohtsuka, E., Okada, Y., and Tanaka, K. (1994) The XPA protein is a zinc mctalloprotein with an ability to recognize various kinds of DNA damage. Mutat. Res. DNA Repair 315, 229-237
25. Kuraoka, I., Morita, E. H., Saijo, M., Matsuda, T., Morikawa, K., Shirakawa, M., and Tanaka, K. (1996) Identification of a damaged-DNA binding domain of the XPA protein. Mutat. Res. 362, 87-95
26. Chu, G., and Chang, E. (1988) Xeroderma pigmentoeum group E cells lack a nuclear factor that binds to damaged DNA. Science 242, 564-567
27. Vaisman, A., and Chaney, S. G. (1995) Induction of UV-damage recognition protein by cisplatin treatment. Biochemistry 34, 105-114
28. Vaisman A., Keeney, S., Nichols, A. F., Linn, S., and Chancy, S. G. (1996) Cisplatin-induced alterations in the expression of the mRNAs for UV-damage recognition protein. Oncol. Res. 8, 7-12
29. Bustin, M., and Reeves, R. (1906) High-mobility group chromosomal proteins: architectural components that facilitate chromatin function. Prog. Nucleic Adds Res. Mol. Biol. 54, 35-100
30. Landsman, D., and Bustin, M. (1993) A signature for the HMG-1 box DNA-binding proteins. BioEssays 15, 539-546
31. Grosschedl, R., Giese, K., and Pagel, J. (1994) HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet, 10, 94-100
32. Zlatanova, J., and van Holde, K. (1998) Binding to four-way junction DNA: a common property of architectural proteins? FASEB J., in press
33. Locker, D., Decoville, M., Maurizot, J. C., Bianchi, M. E., and Leng, M. (1995) Interaction between cisplatin-modified DNA and the HMG boxes of HMG 1: DNase I footprinting and circular dichroism.J. Mol. Biol. 246, 243-247
34. Treiber, D. K., Zhai, X., Jantzen, H.-M., and Essigmann, J. M. (1994) Cisplatin-DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor). Proc. Natl. Acad. Sci. USA 91, 5672-5076
35. McA'Nulty, M. M., Whitehead, J. P., and Lippard, S. J. (1996) Binding of Ixrl, a yeast HMG-domain protein, to cisplatin-DNA adducts in vitro and in vivo. Biochmistry 35, 6089-6099
36. Kane, S. A., and Lippard, S. J. (1996) Photoreactivity of platinum(II) in cisplatin-modified DNA affords specific cross-links to HMG domain proteins. Biochemistry 35, 2180-2187
37. Chow, C. S., Whitehead, J. P., and Lippard, S. J. (1994) HMG domain proteins induce sharp bends in cisplatin-modified DNA. Btochemistry 33, 13124-15130
38. Dunham, S. U., and Lippard, S. J. (1997) DNA sequence context and protein composition modulate HMG-domain protein recognition of cisplatin-modified DNA. Biochemistry 36, 11428-11436
39. Chow, C. S., Barnes, C. M., and Lippard, S.J. (1995) A single HMG domain in high-mobility group 1 protein binds to DNAs as small as 20 base pairs containing the major cisplatin adduct. Biochemistry 34, 2956-2964
40. Lawrence, D. L., Engelsberg, B. N., Farid, R. S., Hughes, E. N., and Billings, P. C. (1993) Localization of the binding region of high mobility group protein 2 to cisplatin-damaged DNA. J. Biol. Chem. 268, 23940-23945
41. Yaneva, J., Leuba, S. H., van Holde, K., and Zlatanova, J. (1997) The major chromatin protein histone H1 binds preferentially to cis-platinum-damaged DNA. Proc, Natl. Acad. Sci. USA 94, 13448-13451
42. Zlatanova, J., and van Holde, K. (1996) The linker histones and chromatin structure: new twists. Prog. Nucleic Acids Res. Mol. Biol. 52, 217-259
43. van Holde, K. E. (1988) Chromatin. Springer-Verlag, New York
44. van Holde, K., and Zlatanova, J. (1996) Chromatin architectural proteins and transcription factors: a structural connection. BiEssays 18, 697-700
45. Huang, J.-C., Zambie, D. B., Reardon. J. T., Lippard, S. J., and Sancar, A. (1994) HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease. Proc. Natl. Acad. Sci. 91, 10394-10398.
46. Zamble, D. B., Mu, D., Reardon, J. T., Sancar, A., and Lippard, S. J. (1996) Repair of cisplatin-DNA adducts by the mammalian excision nuclease. Biochemistry 35, 10004-10013
47. Brown, S. J., Kellett, P. J., and Lippard, S. J. (1993) Ixrl, a yeast protein that binds to platinated DNA and confers sensitivity to cisplatin. Science 261, 603-605
48. McA'Nulty, M. M., and Lippard, S. J. (1996) The HMG-domain protein Ixrl blocks excision repair of cisplatin-DNA adducts in yeast. Mutat. Res. 362, 75-86
49. Murchie, A. I. H., and Ulley, D. M. J. (1993) T4 endonuclease VII cleaves DNA containing a cisplatin adduct. J. Mol. Biol. 233, 77-85
50. Fox, M. E., Feldman, B. J., and Chu, G. (1994) A novel role for DNA photolyase: binding to DNA damaged by drugs is associated with enhanced cytotoxicity in Sacchawmyces cerevisiae. Mol, Cell Biol. 14, 8071-8077
51. Özer, Z., Reardon, J. T., Hsu, D. S., Malhorta, K., and Sancar, A. (1995) The other function of DNA photolyase: stimulation of excision repair of chemical damage to DNA. Biochemistry 34, 15886-15889
52. Dabholkar, M., Bostick-Bruton, F., Weber, C., Bohr, V. A., Egwuagu. C., and Reed, E. (1992) ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients.J. Natl. Cancer Inst. 84, 1512-1517
53. 4-methylthymine, or the cisplatin d(GpG) adduct. Proc. Natl. Acad. Sci. USA 93, 6443-6447
54. Turchi, J. J., and Henkels, K. (1996) Human Ku autoantigen binds cisplatin-damaged DNA but fails to stimulate human DNA-activated protein kinase. J. Biol. Chem. 271, 13861-13867
55. Clugston, C. K., McLaughlin, K., Kenny, M. K., and Brown, R. (1992) Binding of human single-stranded DNA binding protein to DNA damaged by the anticancer drug cw-diamminedichlo-roplatinum (II). Cancer Res. 52, 6375-6379
56. Mello, J. A., Acharya, S., Fishel, R., and Essigmann, J. M. (1996) The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin. Chem. Biol. 3, 579-589
57. Pil, P. M., and Lippard, S. J. (1992) Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin. Science 256, 234-237
58. Billings, P. C., Davis, R. J., Engelsberg, B. N., Skov, K. A., and Hughes, E. N. (1992) Characterization of high mobility group protein binding to cisplatin-damaged DNA. Biochem. Biophys. Res. Commun. 188, 1286-1294
59. Turchi, J. J., Li, M., and Henkels, K. M. (1996) Cisplatin-DNA binding specificity of calf high-mobility group 1 protein. Biochemistry 35, 2992-3000
60. Churchill, M. E. A., Jones, D. N., Glaser, T., Hefner, H., Searles, M. A., and Travers, A. A. (1995) HMG-D is an architecture-spe-cific protein that preferentially binds to DNA containing the dinucleotide TG. EMBO J. 14, 1264-1275
61. Bruhn, S. L., Pil, P. M., Essigmann, J. M., Housman, D. E., and Lippard, S. J. (1992) Isolation and characterization of human cDNA clones encoding a high mobility group box protein that recognizes structural distortions to DNA caused by binding of the anticancer agent cisplatin. Proc. Natl. Acad. Sci. USA 89, 2307-
62. Shirakata, M., Hüppi, K., Usuda, S., Qkazaki, K., Yoshida, K., and Sakano, H. (1991) HMGl-related DNA-binding protein isolated with V-(D)-J recombination signal probes. Mol. Cell Biol. 11, 4528-4536
63. Bruhn, S. L., Housman, D. E., and Lippard, S. J. (1993) Isolation and characterization of cDNA clones encoding the Drosophila homolog of the HMG-box SSRP family that recognizes specific DNA structures. Nucleic Acids Res. 21, 1643-1646